Sigma Healthcare : Annual Review 20212022

CONTENTS

• 02 Overview

• 04 Chairman's Report

• 08 CEO and Managing Director's Report

• 10 Wholesale

• 14 Community Pharmacy

• 18 Logistics

• 22 MPS Connect

• 24 Board of Directors

• 26 Key Corporate Contacts

• 28 Consolidated Statement of Comprehensive Income

• 29 Consolidated Balance Sheet

• 30 Five Year Summary

• 32 Contact

ABN 15 088 417 403

Supporting the healthcare needs of communities across Australia through daily delivery of medicines, and providing services and programs to support our pharmacy brands.

At our core, we are a leading pharmaceutical wholesaler focused on supporting Australian communities. We aim to build relationships that reward our partners, benefit consumers and optimise our core capabilities to maximise the value we create.

WE PARTNER WITH

Connecting pharmacists to aged care homes and community care customers through world-class, end-to-end medication management solutions that promote better health outcomes for our community.

Hospitals

Delivering the full range of PBS, Section 100, Schedule 8 and Cold Chain medications as well as medical devices and equipment nationally.

Suppliers

National contract logistics services to pharmaceutical, medical consumable and FMCG sectors, backed by quality standards and certifications.

Sigma Healthcare Limited - Annual Review 2021/22

01

OVERVIEW

Sigma has navigated through an extended period of transformation and investment that has resulted in world-class infrastructure to sustain and support business growth over the long term. While our financial performance this year was impacted by costs incurred to strengthen the Sigma business, we are now preparing for the next phase by simplifying our business and leveraging our assets for growth.

9	220m	>11,300	>4,600
Units distributed
Distribution	Over the counter	Pharmaceutical
per year
Centres	products	products